Genes, muscles, and answers: how genetic counseling can help with neuromuscular diseases

Neuromuscular diseases (NMDs) encompass a wide range of disorders that can affect the muscles and the nerves controlling them. From Duchenne muscular dystrophy to spinal muscular atrophy (SMA), these diseases present significant challenges for patients and their families, especially in understanding the underlying causes, disease progression, and available treatment options. One crucial element of [...]

By , |2025-02-24T10:16:46+00:00February 28, 2025|News, Post blog|

CoMPaSS-NMD seminar – Omics analysis of skeletal muscle homeostasis under normal and pathological conditions

Join us for this seminar as we delve into the complex and fascinating world of muscle behavior, exploring both normal function and the changes that occur in neuromuscular diseases. Who should attend? The workshop is primarily aimed at healthcare professionals and researchers in NMD but is open to anyone interested. DATE: 11 March 2025 [...]

By |2025-02-12T15:25:39+00:00February 11, 2025|Events, News|

AI and genetics are changing the future of muscular dystrophy diagnosis

Understanding muscular dystrophy through AI and genetics The power of precision medicine in neuromuscular disorders Muscular dystrophy is a complex group of genetic disorders that progressively weaken muscles, affecting mobility and quality of life. Traditional methods of diagnosing and categorizing these conditions rely on symptoms and genetic testing, but a new frontier is emerging. [...]

By , |2025-02-13T15:22:41+00:00January 30, 2025|News, Post blog|

A faster diagnosis of neuromuscular diseases: the CoMPaSS NDM project

The Italian patient association ACMT-Rete per la Malattia di Charcot-Marie-Tooth published an article about our project CoMPaSS-NMD. Even with advanced tools for diagnosing neuromuscular diseases like Charcot-Marie-Tooth, many patients still don't get a clear diagnosis. This is a major hurdle for clinical trials. They are supporting our European project CoMPaSSNMD which will help speed up [...]

By |2024-12-17T09:18:50+00:00December 17, 2024|News|

International Rare Diseases Research Consortium Diagnostic Scientific Committee has a CoMPaSS-NMD member

Congratulations to Joanna Polanska from Politechnika Śląska! We're thrilled that our AI & tech expert has been accepted as a member of the International Rare Diseases Research Consortium (IRDiRC) Diagnostic Scientific Committee. The IRDiRC DSC is a prestigious committee dedicated to accelerating rare disease diagnosis and research, ensuring all patients with suspected rare diseases [...]

By |2024-12-10T10:50:39+00:00December 10, 2024|News|

Individual genetic background: the architect of human diversity

What can our genetic background reveal? Unlocking new possibilities for neuromuscular disorder care through CoMPaSS-NMD approach. Our genetic background acts as an "instruction manual" for how we develop, function, and express various traits, including susceptibility to diseases, physical features, and even behaviors. For patients with neuromuscular disorders, this genetic diversity plays a crucial role [...]

By , |2024-12-10T10:49:41+00:00December 4, 2024|News|

Newsletter Issue 1 – October 2024

Your health, our CoMPaSS: Welcome to the CoMPaSS-NMD Newsletter! We are thrilled to launch the first issue of our project newsletter, keeping you informed about the exciting progress of CoMPaSS-NMD (Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders). In this issue: 1. A project overview Our objectives: Faster and more accurate diagnoses [...]

By |2024-11-18T13:05:21+00:00October 31, 2024|News|

Artificial Intelligence: Between Nobel Prizes and European Health Projects

What do the 2024 Nobel Prizes in Physics and Chemistry have in common with the CoMPaSS-NMD Project? Two words: Artificial Intelligence (AI). "For fundamental discoveries and inventions that have made machine learning possible with artificial neural networks". This is the official recognition given to the 2024 Nobel Prize in Physics, jointly awarded to John [...]

By |2024-11-18T13:05:07+00:00October 11, 2024|News, Post blog|

Empowering the Next Generation of NMD Researchers: The CoMPaSS-NMD YIT Initiative

The CoMPaSS-NMD project is at the forefront of developing innovative computational approaches to revolutionize patient stratification in neuromuscular disorders (NMDs). To support this mission, the Young Investigator Training (YIT) initiative was established to foster the growth of young researchers in the field. The YIT Initiative: the 2024 summer edition  The YIT 1 program, from [...]

By |2024-11-18T13:05:07+00:00September 1, 2024|News|

CoMPaSS-NMD webinar – Unmet Needs in Muscle Disorders: Can AI Provide the Solution?

CoMPaSS-NMD launchs its first NMD awareness webinar titled Unmet Needs in Muscle Disorders: Can AI Provide the Solution? Join us for a groundbreaking webinar to explore the potential of artificial intelligence (AI) in revolutionizing the diagnosis and treatment of neuromuscular disorders (NMDs). Leading experts in neurology, molecular genetics, and AI will discuss the critical [...]

By |2024-11-18T13:05:07+00:00July 30, 2024|News|
Go to Top